P27708 (PYR1_HUMAN) Homo sapiens (Human)
Multifunctional protein CAD UniProtKBInterProSTRINGInteractive Modelling
2225 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
52 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Aspartate transcarbamoylase domain of human CAD in apo form | homo-3-mer | 3×EDO; 1×GOL; | ||||
| Assess | ||||||
| Aspartate transcarbamoylase domain of human CAD bound to carbamoyl phosphate | homo-3-mer | 3×CP; | ||||
| Assess | ||||||
| Aspartate transcarbamoylase domain of human CAD bound to PALA | homo-3-mer | 3×PAL; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD with incomplete active site, obtained r… | homo-2-mer | 10×FMT; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 6.5 | homo-2-mer | 2×DOR; 2×NCD; 8×ZN; 8×FMT; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 5.5 | homo-2-mer | 2×DOR; 2×NCD; 4×ZN; 8×FMT; | ||||
| Assess | ||||||
| Hybrid dihydroorotase domain of human CAD with E. coli flexible loop, bound to dihydroorotate | homo-2-mer | 6×FMT; 4×ZN; 2×DOR; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 7.5 | homo-2-mer | 6×ZN; 2×DOR; 2×NCD; 6×FMT; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 7.0 | homo-2-mer | 6×ZN; 6×FMT; 2×DOR; 2×NCD; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563A co-crystallized with carbamoyl aspartate at pH 7.0 | homo-2-mer | 8×ZN; 6×FMT; 2×DOR; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 8.0 | homo-2-mer | 6×ZN; 2×NCD; 6×FMT; 2×DOR; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD bound to the inhibitor fluoroorotate at… | homo-2-mer | 4×ZN; 4×FMT; 2×FOT; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD bound to the inhibitor fluoroorotate at… | homo-2-mer | 6×ZN; 4×FMT; 2×FOT; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD C1613S mutant bound to substrate at pH … | homo-2-mer | 2×ORO; 4×ZN; 2×NCD; 8×FMT; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD E1637T mutant bound to substrate at pH … | homo-2-mer | 4×ZN; 6×FMT; 2×NCD; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563A co-crystallized with carbamoyl aspartate at pH 7.5 | homo-2-mer | 8×ZN; 6×FMT; 2×DOR; | ||||
| Assess | ||||||
| Mutant R1789Q of the dihydroorotase domain of human CAD protein bound to the substrate dihydroorota… | homo-2-mer | 2×DOR; 4×GOL; 6×FMT; 8×ZN; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 6.0 | homo-2-mer | 2×DOR; 2×NCD; 8×ZN; 8×FMT; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 7.0 | homo-2-mer | 8×ZN; 2×NCD; 6×FMT; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 6.5 | homo-2-mer | 8×ZN; 2×NCD; 6×FMT; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 7.0 | homo-2-mer | 8×ZN; 2×DOR; 6×FMT; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 7.5 | homo-2-mer | 6×ZN; 2×NCD; 6×FMT; | ||||
| Assess | ||||||
| Mutant K1482M of the dihydroorotase domain of human CAD protein bound to the substrate dihydroorota… | homo-2-mer | 2×GOL; 2×DOR; 14×ZN; 24×FMT; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD in apo- form obtained recombinantly fro… | homo-2-mer | 8×ZN; 8×FMT; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 6.5 | homo-2-mer | 8×ZN; 6×FMT; 2×DOR; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563A apo structure | homo-2-mer | 8×ZN; 10×FMT; | ||||
| Assess | ||||||
| Mutant K1556T of the dihydroorotase domain of human CAD protein bound to the inhibitor fluoroorotate | homo-2-mer | 10×FMT; 2×FOT; 4×ZN; 2×NA; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563T apo structure | homo-2-mer | 8×ZN; 12×FMT; | ||||
| Assess | ||||||
| Mutant R1617Q of the dihydroorotase domain of human CAD protein bound to the inhibitor fluoroorotate | homo-2-mer | 2×FOT; 6×FMT; 4×ZN; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563Y apo structure | homo-2-mer | 8×ZN; 8×FMT; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD C1613S mutant in apo-form at pH 7.0 | homo-2-mer | 6×ZN; 8×FMT; | ||||
| Assess | ||||||
| Mutant R1785C of the dihydroorotase domain of human CAD protein bound to the substrate carbamoyl as… | homo-2-mer | 2×NCD; 4×FMT; 2×DOR; 6×ZN; | ||||
| Assess | ||||||
| Mutant R1722W of the dihydroorotase domain of human CAD protein bound to the substrate carbamoyl as… | homo-2-mer | 2×NCD; 8×FMT; 4×GOL; 6×ZN; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD C1613S mutant in apo-form at pH 6.0 | homo-2-mer | 4×ZN; 8×FMT; | ||||
| Assess | ||||||
| Mutant K1482M of the dihydroorotase domain of human CAD protein bound to the inhibitor fluoorotate | homo-2-mer | 2×FOT; 10×ZN; 16×FMT; | ||||
| Assess | ||||||
| Mutant R1722W of the dihydroorotase domain of human CAD protein bound to the inhibitor fluoorotate | homo-2-mer | 2×FOT; 2×GOL; 6×FMT; 4×ZN; | ||||
| Assess | ||||||
| Mutant K1556T of the dihydroorotase domain of human CAD protein bound to the substrate carbamoyl as… | homo-2-mer | 6×FMT; 2×NCD; 4×ZN; | ||||
| Assess | ||||||
| Mutant R1789Q of the dihydroorotase domain of human CAD protein bound to the inhibitor fluoorotate | homo-2-mer | 2×FOT; 4×ZN; 10×FMT; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain of human CAD in apo- form obtained recombinantly fro… | homo-2-mer | 8×ZN; 8×FMT; | ||||
| Assess | ||||||
| Hybrid dihydroorotase domain of human CAD with E. coli flexible loop, bound to fluoroorotate | homo-2-mer | 4×ZN; 2×FOT; 2×FMT; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563L apo structure | homo-2-mer | 8×ZN; 8×FMT; | ||||
| Assess | ||||||
| Mutant R1617Q of the dihydroorotase domain of human CAD protein bound to the substrate carbamoyl as… | homo-2-mer | 2×NCD; 4×FMT; 4×ZN; 2×NA; | ||||
| Assess | ||||||
| Mutant K1482M of the dihydroorotase domain of human CAD protein in apo form | homo-2-mer | 2×GOL; 12×ZN; 6×FMT; | ||||
| Assess | ||||||
| Mutant R1475Q of the dihydroorotase domain of human CAD protein in apo form | homo-2-mer | 6×ZN; 8×FMT; | ||||
| Assess | ||||||
| Mutant R1810Q of the dihydroorotase domain of human CAD protein bound to the substrates | homo-2-mer | 2×NCD; 2×FMT; 10×ZN; | ||||
| Assess | ||||||
| Hybrid dihydroorotase domain of human CAD with E. coli flexible loop in apo state | monomer | 2×ZN; 4×FMT; | ||||
| Assess | ||||||
| Crystal structure of the dihydroorotase domain (K1556A) of human CAD | monomer | 1×ZN; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563T co-crystallized with carbamoyl aspartate at pH 7.5 | monomer | 4×ZN; 1×DOR; 4×FMT; 1×GOL; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563T co-crystallized with carbamoyl aspartate at pH 7.0 | monomer | 4×ZN; 1×DOR; 4×FMT; | ||||
| Assess | ||||||
| Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 7.5 | monomer | 3×ZN; 3×FMT; 1×DOR; | ||||
| Assess | ||||||
| Crystal structure of the human dihydroorotase domain in complex with malic acid | monomer | 1×LMR; 2×ZN; | ||||
| Assess | ||||||
| Crystal structure of the human dihydroorotase domain in complex with the anticancer drug 5-fluorour… | monomer | 1×URF; 2×ZN; | ||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5ynz.1.A | monomer | 0.88 | 1×ZN; | 99.74 | ||
| Assess | ||||||
| 5g1p.2.A | monomer | 0.78 | 100.00 | |||
| Assess | ||||||
| 6w2j.1.A | monomer | 0.75 | 51.87 | |||
| Assess | ||||||